Obama biologic approval reforms to be debated

The goal of expanding the availability of generic forms of biologic drugs - and a variety of congressional efforts to fulfil the  administration's goal, as proposed by the administration of US President  Barack Obama, will be discussed on April 21 at the National Press Club  in Washington DC when the Jefferson School of Population Health hosts a  forum on the quality and safety issues surrounding the creation of a  regulatory pathway for follow-on biologic drugs. Attendees will also  offer recommendations and key take-away messages for policy makers on  Capitol Hill and in the administration.

The outcome of this debate is likely to have far-reaching implications  with regard to access, cost, safey, and therapeutic impact for thousands  of patients with serious, life-threatening and chronic diseases. For  this reason, it is critical that decision makers hear from all key  stakeholders who have information and insights on the various touch  points of this important health care issue before reaching a  conclusion.